NCT03348969View on ClinicalTrials.gov

Neoadjuvant Short-term Intensive Chemoresection Versus Standard Adjuvant Intravesical Instillations in NMIBC

PHASE4Active, not recruitingINTERVENTIONAL

Enrollment

120

Participants

Timeline

Start Date

November 1, 2017

Primary Completion Date

June 11, 2019

Study Completion Date

December 31, 2024

Conditions

Bladder Cancer

Interventions

DRUG

Mitomycin c

Neoadjuvant Mitomycin C

Trial Locations (1)

8200

Aarhus University Hospital, Aarhus

All Listed Sponsors

lead

Jørgen Bjerggaard Jensen

OTHER

NCT03348969 - Neoadjuvant Short-term Intensive Chemoresection Versus Standard Adjuvant Intravesical Instillations in NMIBC | Biotech Hunter | Biotech Hunter